SIGA Technologies, Inc. (OTCMKTS:SIGA) CFO Daniel J. Luckshire bought 5,000 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were bought at an average price of $4.34 per share, with a total value of $21,700.00.
Shares of SIGA stock opened at $4.55 on Friday. The company has a 50-day simple moving average of $5.12 and a 200 day simple moving average of $5.35. SIGA Technologies, Inc. has a 52 week low of $4.28 and a 52 week high of $8.09.
SIGA Technologies (OTCMKTS:SIGA) last announced its quarterly earnings results on Tuesday, November 5th. The biotechnology company reported ($0.03) EPS for the quarter. The company had revenue of $8.11 million for the quarter.
SIGA Technologies Company Profile
SIGA Technologies, Inc is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company’s lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield).
Further Reading: Overbought
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.